Conflict of Interest
The new eCOI system is now up and running! To enter a new disclosure you must use either Firefox or Safari (not Internet Explorer) for your browser. Please remember, you will need your WSU AccessID and password to login. If you do not have a WSU AccessID, please contact Ginette Borovicka at 313-577-1862 or email@example.com.
If for some reason you need access to the old version of the form, please contact Ginette Borovicka directly at 313-577-1862.
Wayne State University encourages external activities that enhance an employee’s value to WSU. WSU’s presence in local, national, or international communities, provides public service, or brings cutting edge research to the public via industry partnerships. In order to protect the public trust and promote objectivity in these activities, the University has adopted a Research Policy on Individual and Institutional Financial Conflict of Interest. This policy establishes standards to ensure that there is no reasonable expectation that WSU employees will be biased in these endeavors by competing financial interests.
Please see the new Research Policy on Conflict of Interest (PDF).
NIH issues final rule on Financial Conflict of Interest - August 24th, 2012
Revised Conflict of Interest rules issued!
Institutions receiving Public Health Service funding must be in full compliance with the revised conflict of interest rules that began August 24, 2012. The new rules modify the definitions, thresholds, and requirements for disclosing, reviewing, managing, and reporting the financial relationships between research personnel and outside entities. The Wayne State University FCOI Committee has announced a new research policy and disclosure form which are now available.
Details can be found in the NIH Notice published on August 23, 2011 and in the At-a-Glance: NIH Conflicts of Interest Revisions document (PDF)
NIH Provides Policy Clarification Concerning Disclosure Requirements for Reimbursed and Sponsored Travel - 42 CFR Part 50 Subpart F, "Responsibility of Applicants for Promoting Objectivity in Research for Which PHS Funding is Sought"
Consistent with NIH’s March 2012 policy clarification concerning disclosure requirements for reimbursed and sponsored travel (See Frequently Asked Questions E.1. posted on NIH’s Office of Extramural Research, Financial Conflict of Interest (FCOI) Web site), Investigators who are planning to participate in PHS-funded research must disclose their Significant Financial Interests (SFIs) over the previous twelve-month period to their Institution no later than at the time of application for PHS-funded research. As with other SFIs defined in 42 CFR 50.603, the Investigator must disclose his/her interests, as well as those of the Investigator’s spouse and dependent children, that reasonably appear to be related to the Investigator’s institutional responsibilities.
During the rule making process, we considered how to best balance the need for the Institution to have information on an Investigator’s reimbursed or sponsored travel versus the added burden on the Investigator to disclose the value of travel reimbursements. Particularly in the case of sponsored travel, which is paid on behalf of the Investigator, the exact monetary value may not be readily available to the Investigator. The Final Rule, therefore, does not require Investigators to disclose the monetary value of the sponsored or reimbursed travel; rather, it is the Institution’s responsibility to determine upon review if further information, such as the monetary value of the travel, is needed. Accordingly, the Final Rule does not impose a general requirement to apply the de minimis threshold to all reimbursed or sponsored travel disclosure. With that said, in response to requests for further clarification, we want to make clear that Institutions may, within the discretion afforded by the Final Rule, impose the $5,000 de minimis threshold to reimbursed or sponsored travel disclosure in their institutional policies which specify the disclosure details. For example, consistent with the requirement for other types of financial interests within the regulatory definition of SFI, Institutions could apply the de minimis threshold when aggregated per entity. Disclosure of reimbursed or sponsored travel is also subject to the exclusions described in 50.603(3). However, it remains NIH’s position that Investigators must disclose their SFIs, including reimbursed or sponsored travel, no later than at the time of application over the previous twelve-month period (initial disclosure), which is also the same disclosure requirement that applies to all other SFIs. The initial disclosure of SFIs over the previous twelve-month period provides baseline information that allows Institutions to take into account whether Investigators have an ongoing financial relationship with an entity providing a payment or reimbursement or whether the payment or reimbursement was limited in duration. Once Investigators have made their initial disclosure, they are required to update their disclosures within 30 days of discovering or acquiring a new SFI and annually during the period of award. We believe that these disclosure requirements provide Institutions with a comprehensive understanding of an Investigator’s SFIs related to the PHS-funded research project.
Frequently asked questions
In addition to this Notice, NIH will post and update Frequently asked questions regarding the new NIH rule on the NIH Office of Extramural Research, Financial Conflict of Interest website for reference by the grantee community to capture the clarification provided above.
For PHS funded research projects, WSU will ensure public accessibility of information concerning any FCOI associated with a project. Information concerning identified FCOI's held by investigators will be made available within 5 days of a written request. To request such information, please complete the Request for Information form (PDF) and submit to: firstname.lastname@example.org.
If you are submitting to the IRB and have disclosed a Financial Conflict of Interest, be certain to include a copy of the Management Plan, along with a copy of the signed Acceptance Memorandum that you received from the FCOI Committee. If you do not present these documents to the Institutional Review Board office, they will not accept your submission as complete.
New Conflict of Interest CITI training module
Please be aware that there is a new Conflict of Interest training module that can be accessed in through the CITI website. You must complete this training prior to completing the FCOI Disclosure form. To access the online training modules from CITI go to:
Step-by-step instructions to using CITI.
Once you have signed in to the CITI website, you may need to click on the "Add a Course or Update your Learner Group" link. You will then be taken to the Select Curriculum page where you may choose the Conflicts of Interest course.
If you have questions regarding the CITI training please contact the IRB office at (313) 577-1628. Or you may contact CITI directly at (305) 243-7970. For FAQs and general CITI support inquiries, visit the CITI KnowledgeBase.
- AAMC Conflicts of Interest and Transparency Initiatives
- NIH Conflict of Interest Information Resources
- AAU Conflicts of Interest and Misconduct
- FDA IRB Review
- National Science Foundation (NSF) Investigator Financial Disclosure Policy
- Federation of American Societies for Experimental Biology (FASEB) COI Toolkit
- AAMC Task Force Report on Industry Funding of Medical Education to the AAMC Council
- Federal Demonstration Partnership – The National Academies